Biosensors & bioelectronics

DNA-triggered CRISPR/Cas12a circuit for highly sensitive and flexible biosensing

Updated

Abstract

The CBD biosensing platform achieves a detection limit of 14 CFU/mL for methicillin-resistant Staphylococcus aureus.

  • A bulge DNA (BD)-driven activation circuit enhances the sensitivity of the CRISPR/Cas12a biosensing tool.
  • For nucleic acid targets, the system initiates a positive feedback loop that amplifies detection signals.
  • Detection of pesticides and mycotoxins is possible at the picogram-per-milliliter level through a universal single-stranded DNA activator.
  • An 'OR' logic gate allows for simultaneous detection of two mycotoxins, demonstrating multiplexing capabilities.
  • The CBD platform shows versatility for both nucleic acid and non-nucleic acid target detection.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free